https://doi.org/10.1186/s12967-022-03427-2
L
Lei Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
214
Papers
3.4K
Citations
33
h-index
70
i10-index
Lei Li is an academic researcher from Qingdao University. The author has contributed to research in topics: Renal cell carcinoma treatment & Prostate Cancer Treatment and Research & Renal and related cancers. The author has an h-index of 33, co-authored 182 publications.
ORCID: 0000-0001-9231-3378Papers by this author
works5-methylcytosine RNA methyltransferases and their potential roles in cancer
2022 · Journal of Translational Medicine · 207 citations
TAK1 regulates caspase 8 activation and necroptotic signaling via multiple cell death checkpoints
2016 · Cell Death and Disease · 63 citations
https://doi.org/10.1038/cddis.2016.294
PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer
2023 · Cell Death and Disease · 47 citations
https://doi.org/10.1038/s41419-023-06148-6
Induction of ferroptosis by carnosic acid-mediated inactivation of Nrf2/HO-1 potentiates cisplatin responsiveness in OSCC cells
2022 · Molecular and Cellular Probes · 44 citations
https://doi.org/10.1016/j.mcp.2022.101821
Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways
2017 · Scientific Reports · 36 citations
https://doi.org/10.1038/s41598-017-15239-2
A Zic2/Runx2/NOLC1 signaling axis mediates tumor growth and metastasis in clear cell renal cell carcinoma
2021 · Cell Death and Disease · 36 citations
https://doi.org/10.1038/s41419-021-03617-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat